Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

NCT02914600 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1188

Enrollment

INDUSTRY

Sponsor class

Stopped development program for filgotinib for participants with Crohn's disease has been stopped

Conditions

Crohn's Disease

Interventions

DRUG: Filgotinib
DRUG: Placebo

Sponsor

Lakefront Biotherapeutics NV

Collaborators

[object Object]